NDAORALSUSPENSION
Approved
Aug 1949
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 13h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Triple Sulfas is a fixed-dose combination of three sulfonamide antibiotics (sulfadiazine, sulfamerazine, and sulfamethazine) approved as an oral suspension in 1949. This antibiotic combination was historically used to treat bacterial infections across multiple therapeutic areas. The product represents a legacy small-molecule antimicrobial with a long clinical history.
LOE Approaching
This legacy product is approaching loss of exclusivity with minimal commercial momentum; teams are typically small and focused on compliance and supply continuity rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Career opportunities on Triple Sulfas are limited and specialized, focused on regulatory maintenance, supply continuity, and institutional accounts rather than growth-oriented functions. This role suits professionals seeking stability in legacy product management or those transitioning into operational or compliance-focused careers rather than high-visibility commercial launches.
Regulatory Affairs Specialist
Worked on TRIPLE SULFAS at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.